Blog

FDA plans to speed path to approval for some gene therapies – Stat – STAT


STAT

FDA plans to speed path to approval for some gene therapies – Stat
STAT
The Food and Drug Administration will soon be alerting companies that certain gene therapies in development can qualify for less arduous review at the agency.
FDA chief Gottlieb is building a regulatory speedway to accelerate …Endpoints News


Gene Therapies That Could Transform Diseases Get Easier FDA …Bloomberg
Gottlieb: FDA Prepping for Push of New Gene and Cell TherapiesRegulatory Focus
StreetInsider.com
all 7 news articles »

2018-05-22 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.